KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mgp Ingredients (MGPI) Common Equity (2016 - 2025)

Mgp Ingredients (MGPI) has disclosed Common Equity for 16 consecutive years, with $718.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Common Equity fell 13.71% to $718.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $718.4 million, a 13.71% decrease, with the full-year FY2025 number at $718.4 million, down 13.71% from a year prior.
  • Common Equity was $718.4 million for Q4 2025 at Mgp Ingredients, down from $855.2 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $912.9 million in Q3 2024 to a low of $278.5 million in Q1 2021.
  • A 5-year average of $748.9 million and a median of $791.5 million in 2023 define the central range for Common Equity.
  • Peak YoY movement for Common Equity: surged 145.41% in 2021, then fell 13.71% in 2025.
  • Mgp Ingredients' Common Equity stood at $644.3 million in 2021, then increased by 15.74% to $745.6 million in 2022, then rose by 13.87% to $849.1 million in 2023, then dropped by 1.95% to $832.5 million in 2024, then dropped by 13.71% to $718.4 million in 2025.
  • Per Business Quant, the three most recent readings for MGPI's Common Equity are $718.4 million (Q4 2025), $855.2 million (Q3 2025), and $840.1 million (Q2 2025).